Hostname: page-component-848d4c4894-pftt2 Total loading time: 0 Render date: 2024-05-18T19:01:02.029Z Has data issue: false hasContentIssue false

Incidence and outcomes of hospital-associated respiratory virus infections by viral species

Published online by Cambridge University Press:  11 December 2023

Joshua G. Petrie*
Affiliation:
Center for Clinical Epidemiology and Population Health, Marshfield Clinic Research Institute, Marshfield, Wisconsin
Riley Moore
Affiliation:
Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan
Adam S. Lauring
Affiliation:
Department of Microbiology and Immunology and Division of Infectious Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan
Keith S. Kaye
Affiliation:
Division of Allergy, Immunology and Infectious Diseases, Department of Medicine, Rutgers Robert Wood Johnson School of Medicine, New Brunswick, New Jersey
*
Corresponding author: Joshua G. Petrie; Email: petrie.joshua@marshfieldresearch.org

Abstract

Background:

Although the incidence of hospital-associated respiratory virus infection (HARVI) is well recognized, the risk factors for infection and impact on patient outcomes are not well characterized.

Methods:

We identified a cohort of all inpatient admissions ≥24 hours duration at a single academic medical center from 2017 to 2020. HARVI were defined as respiratory virus detected in a test ordered after the 95th percentile of the virus-specific incubation period. Risk factors for HARVI were assessed using Cox proportional hazards models of the competing outcomes of HARVI and discharge. The associations between time-varying HARVI status and the rates of ICU admission, discharge, and in-hospital death were estimated using Cox-proportional hazards models in a competing risk framework.

Results:

HARVI incidences were 8.8 and 3.0 per 10,000 admission days for pediatric and adult patients, respectively. For adults, congestive heart failure, renal disease, and cancer increased HARVI risk independent of their associations with length of stay. HARVI risk was also elevated for patients admitted in September–June relative to July admissions. For pediatric patients, cardiovascular and respiratory conditions, cancer, medical device dependence, and admission in December increased HARVI risk. Lengths of stay were longer for adults with HARVI compared to those without, and hospital-associated influenza A was associated with increased risk of death. Rates of ICU admission were increased in the 5 days after HARVI identification for adult and pediatric patients. HARVI was not associated with length of stay or death among pediatric patients.

Conclusions:

HARVI is associated chronic health conditions and increases morbidity and mortality.

Type
Original Article
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

PREVIOUS PRESENTATION. These data were presented in poster 640 at the Society for Healthcare Epidemiology of America Spring Conference on April 14, 2023, in Seattle, Washington.

References

Jain, S, Self, WH, Wunderink, RG, et al. Community-acquired pneumonia requiring hospitalization among US adults. N Engl J Med 2015;373:415427.CrossRefGoogle Scholar
Jain, S, Williams, DJ, Arnold, SR, et al. Community-acquired pneumonia requiring hospitalization among US children. N Engl J Med 2015;372:835845.10.1056/NEJMoa1405870CrossRefGoogle Scholar
Clark, TW, Medina, M, Batham, S, Curran, MD, Parmar, S, Nicholson, KG. Adults hospitalised with acute respiratory illness rarely have detectable bacteria in the absence of COPD or pneumonia; viral infection predominates in a large prospective UK sample. J Infect 2014;69:507515.CrossRefGoogle ScholarPubMed
Perez, A. Respiratory virus surveillance among children with acute respiratory illnesses—new vaccine surveillance network, United States, 2016–2021. Morb Mortal Wkly Rep 2022;71:12531259.CrossRefGoogle Scholar
Zimmerman, RK, Balasubramani, GK, D’Agostino, HEA, et al. Population-based hospitalization burden estimates for respiratory viruses, 2015–2019. Influenza Other Respir Viruses 2022;16:11331140.CrossRefGoogle ScholarPubMed
Petrie, JG, Talbot, TR. Healthcare-acquired viral respiratory diseases. Infect Dis Clin N Am 2021;35:10551075.CrossRefGoogle Scholar
Chow, EJ, Mermel, LA. Hospital-acquired respiratory viral infections: incidence, morbidity, and mortality in pediatric and adult patients. Open Forum Infect Dis 2017;4:ofx006.CrossRefGoogle ScholarPubMed
Choi, H-S, Kim, M-N, Sung, H, et al. Laboratory-based surveillance of hospital-acquired respiratory virus infection in a tertiary-care hospital. Am J Infect Control 2017;45:e45e47.CrossRefGoogle ScholarPubMed
Petrie, JG, Lauring, AS, Martin, ET, Kaye, KS. Hospital-associated respiratory virus infection in children and adults: it does not just occur during cold and flu season. Open Forum Infect Dis 2020;7:ofaa200.CrossRefGoogle Scholar
Most, ZM, Jackson, P, Sebert, M, Perl, TM. Contrasting definitions and incidence of healthcare-associated respiratory viral infections in a pediatric hospital. Infect Control Hosp Epidemiol 2023;44:5561.10.1017/ice.2022.33CrossRefGoogle Scholar
Shi, T, McLean, K, Campbell, H, Nair, H. Aetiological role of common respiratory viruses in acute lower respiratory infections in children under five years: a systematic review and meta-analysis. J Glob Health 2015;5:010408.Google Scholar
Self, WH, Williams, DJ, Zhu, Y, et al. Respiratory viral detection in children and adults: comparing asymptomatic controls and patients with community-acquired pneumonia. J Infect Dis 2016;213:584591.10.1093/infdis/jiv323CrossRefGoogle ScholarPubMed
Shi, T, Arnott, A, Semogas, I, et al. The etiological role of common respiratory viruses in acute respiratory infections in older adults: a systematic review and meta-analysis. J Infect Dis 2020;222:S563S569.CrossRefGoogle ScholarPubMed
Wolkewitz, M, Allignol, A, Harbarth, S, de Angelis, G, Schumacher, M, Beyersmann, J. Time-dependent study entries and exposures in cohort studies can easily be sources of different and avoidable types of bias. J Clin Epidemiol 2012;65:11711180.10.1016/j.jclinepi.2012.04.008CrossRefGoogle ScholarPubMed
Schumacher, M, Allignol, A, Beyersmann, J, Binder, N, Wolkewitz, M. Hospital-acquired infections—appropriate statistical treatment is urgently needed! Int J Epidemiol 2013;42:15021508.CrossRefGoogle ScholarPubMed
Manchal, N, Mohamed, MRS, Ting, M, et al. Hospital-acquired viral respiratory tract infections: an underrecognized nosocomial infection. Infect Dis Health 2020;25:175180.CrossRefGoogle ScholarPubMed
Quan, H, Sundararajan, V, Halfon, P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43:11301139.CrossRefGoogle ScholarPubMed
Feudtner, C, Feinstein, JA, Zhong, W, Hall, M, Dai, D. Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation. BMC Pediatr 2014;14:199.CrossRefGoogle ScholarPubMed
Lessler, J, Reich, NG, Brookmeyer, R, Perl, TM, Nelson, KE, Cummings, DAT. Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis 2009;9:291300.10.1016/S1473-3099(09)70069-6CrossRefGoogle ScholarPubMed
Lau, B, Cole, SR, Gange, SJ. Competing risk regression models for epidemiologic data. Am J Epidemiol 2009;170:244256.CrossRefGoogle ScholarPubMed
Fine, JP, Gray, RJ. A Proportional hazards model for the subdistribution of a competing risk. J Am Statist Assoc 1999;94:496509.CrossRefGoogle Scholar
Valenti, WM, Menegus, MA, Hall, CB, Pincus, PH, Douglas, RG. Nosocomial viral infections: I. Epidemiology and significance. Infect Control 1980;1:3337.CrossRefGoogle ScholarPubMed
Quach, C, Shah, R, Rubin, LG. Burden of healthcare-associated viral respiratory infections in children’s hospitals. J Pediatr Infect Dis 2018;7:1824.CrossRefGoogle ScholarPubMed
Jacobs, SE, Lamson, DM, St. George K, Walsh TJ. Human rhinoviruses. Clin Microbiol Rev 2013;26:135162.10.1128/CMR.00077-12CrossRefGoogle ScholarPubMed
McIntosh, K, Perlman, S, Monto, A, Englund, JA. A proposal to refer to four coronaviruses of limited human virulence ‘common cold coronaviruses.’ J Infect Dis 2022;226:20472049.CrossRefGoogle ScholarPubMed
Louie, JK, Yagi, S, Nelson, FA, et al. Rhinovirus outbreak in a long-term care facility for elderly persons associated with unusually high mortality. Clin Infect Dis 2005;41:262265.CrossRefGoogle Scholar
Zinna, S, Lakshmanan, A, Tan, S, et al. Outcomes of nosocomial viral respiratory infections in high-risk neonates. Pediatrics 2016;138:e20161675.CrossRefGoogle ScholarPubMed
Hand, J, Rose, EB, Salinas, A, et al. Severe respiratory illness outbreak associated with human coronavirus NL63 in a long-term care facility. Emerg Infect Dis 2018;24:19641966.CrossRefGoogle ScholarPubMed
Beury, D, Fléchon, L, Maurier, F, et al. Use of whole-genome sequencing in the molecular investigation of care-associated HCoV-OC43 infections in a hematopoietic stem cell transplant unit. J Clin Virol 2020;122:104206.10.1016/j.jcv.2019.104206CrossRefGoogle Scholar
Veiga, ABG da, Martins, LG, Riediger, I, Mazetto, A, Debur, M do C, Gregianini, TS. More than just a common cold: endemic coronaviruses OC43, HKU1, NL63, and 229E associated with severe acute respiratory infection and fatality cases among healthy adults. J Med Virol 2021;93:10021007.CrossRefGoogle ScholarPubMed
Wolkewitz, M, Cooper, BS, Bonten, MJM, Barnett, AG, Schumacher, M. Interpreting and comparing risks in the presence of competing events. BMJ 2014;349:g5060.10.1136/bmj.g5060CrossRefGoogle ScholarPubMed
WHO statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 Pandemic. World Health Organization website. https://www.who.int/news/item/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic. Accessed May 8, 2023.Google Scholar
Talbot, TR, Hayden, MK, Yokoe, DS, et al. Asymptomatic screening for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) as an infection prevention measure in healthcare facilities: challenges and considerations. Infect Control Hosp Epidemiol 2023;44:27.10.1017/ice.2022.295CrossRefGoogle ScholarPubMed
Chiu, SS, Cowling, BJ, Peiris, JSM, Chan, ELY, Wong, WHS, Lee, KP. Effects of nonpharmaceutical COVID-19 interventions on pediatric hospitalizations for other respiratory virus infections, Hong Kong. Emerg Infect Dis 2022;28:6268.10.3201/eid2801.211099CrossRefGoogle ScholarPubMed
Wee, LE, Conceicao, EP, Sim, XYJ, Ko, KKK, Ling, ML, Venkatachalam, I. Reduction in healthcare-associated respiratory viral infections during a COVID-19 outbreak. Clin Microbiol Infect 2020;26:15791581.CrossRefGoogle ScholarPubMed
Wong, S-C, Lam, GK-M, AuYeung, CH-Y, et al. Absence of nosocomial influenza and respiratory syncytial virus infection in the coronavirus disease 2019 (COVID-19) era: implication of universal masking in hospitals. Infect Control Hosp Epidemiol 2021;42:218221.CrossRefGoogle ScholarPubMed
Most, ZM. Beyond personal protective equipment: adjunctive methods for control of healthcare-associated respiratory viral infections. Curr Opin Infect Dis 2020;33:312.CrossRefGoogle ScholarPubMed
Supplementary material: File

Petrie et al. supplementary material

Petrie et al. supplementary material

Download Petrie et al. supplementary material(File)
File 122.2 KB